CBIO

Crescent Biopharma
CBIO

Overview Fund Trends Analyst Outlook Journalist POV
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$26
126% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
HC Wainwright & Co
HC Wainwright & Co
Mitchell Kapoor
50% 1-yr CBIO win rate
27 Aug ‘25 1 month ago
Jefferies
Jefferies
Akash Tewari
0% 1-yr CBIO win rate
25 Aug ‘25 1 month ago